In approximately 10% of B-cell CLL, the BCL-2 gene is translocated into the immunoglobulin (Ig) loci, leading to abnormally high levels of BCL-2 expression [46]. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.